Skip to content

Gross margin at other companies

Alkermes logo
AlkermesALKS
86.6%+2.2pp
JAN
Janus Living JAN
46.5%+1.2pp

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%
Enterprise value$4.86B+242%
P/E18×
P/S3.5×+2.3×

Profitability

See full
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%

Returns & leverage

See full
Return on equity-117%
Debt / equity-3.5×
Current ratio0.9×0.0×

Where this comes from

Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's gross margin?
Indivior Pharmaceuticals, Inc. (INDV) reported gross margin of 81.3% in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's gross margin changed year-over-year?
Indivior Pharmaceuticals, Inc. 's gross margin increased by 1.9% year-over-year, from 79.8% to 81.3%.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's gross margin?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's gross margin has grown at a -1.2% compound annual growth rate (CAGR), from 83.2% to 80.2%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.